Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

NCT02858076 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT02858076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02858076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2016
Completion date
January 31, 2020
Enrollment
205 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy, vitreous hemorrhage